NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/29/2023
Back to search
Official data from USPTO
ASPEN CLINICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
07/29/2023
Trademark type
Combined
Nice classes
42
Filing date
08/31/2017
Registration date
01/23/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/29/2023
Last transaction
07/29/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
First use anywhere
06/01/2006
First use in commerce
01/01/2007
Drawing code
3
Owner type
16
Owner location
Orem, UT, US
Examiner
LAM, HAI-LY
Law office
M30
Current location
TMO LAW OFFICE 112
Mark description
The mark consists of six overlapping green spiral swirls with orange tear drops in between each swirl forming a circular pattern adjacent to the wording "ASPEN" in green and the wording "CLINICAL RESEARCH" in orange capital letters. The color white represents background and/or transparent areas and is not part of the mark.
Holders and representatives
Holders
Aspen Clinical Research, LLC
Representatives
James C. Watson TRASKBRITT, P.C.
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Pharmaceutical and Bio-pharmaceutical clinical research services through clinical trials in humans
Publications
History of USPTO decisions and trademark events.
24 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/29/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/29/2023
E815
TEAS SECTION 8 & 15 RECEIVED
02/01/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/23/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
01/23/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/07/2017
PUBO
PUBLISHED FOR OPPOSITION
11/07/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/18/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
10/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/02/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
09/19/2017
ALIE
ASSIGNED TO LIE
09/19/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/19/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
09/19/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/19/2017
DOCK
ASSIGNED TO EXAMINER
09/15/2017
DOCK
ASSIGNED TO EXAMINER
09/13/2017
PMSG
PETITION TO DIRECTOR - MAKE SPECIAL - GRANTED
09/13/2017
APET
ASSIGNED TO PETITION STAFF
09/12/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/09/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/08/2017
TRMS
TEAS REQUEST TO MAKE SPECIAL RECEIVED
09/05/2017
NWAP
NEW APPLICATION ENTERED
09/04/2017
Continuous trademark protection
Get notified about every new filing that threatens ASPEN CLINICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.